date:Apr 15, 2013
the year at NOK 480 million compared to NOK 276 in the first quarter of 2012.
The company's total operational earnings (EBIT) per kilo was NOK 8.3 for Norway and NOK 5.9 in Chile.
The results from Chile were impacted by a low price and high biological costs. The result in Chile further underlines the requirement for consolidation in the Chilean industry.
Net interest bearing debt (NIBD) by the end of the quarter was approximately NOK 6,300 million. The payment of Morpol shares affected NIBD b